Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea flag South Korea · Delayed Price · Currency is KRW
86,600
-1,600 (-1.81%)
Last updated: Apr 29, 2026, 2:20 PM KST
9.90%
Market Cap 1.16T
Revenue (ttm) 1.69T
Net Income (ttm) 77.51B
Shares Out 13.18M
EPS (ttm) 5,845.54
PE Ratio 15.09
Forward PE 16.24
Dividend 1,100.00 (1.25%)
Ex-Dividend Date Dec 29, 2025
Volume 22,980
Average Volume 25,592
Open 88,200
Previous Close 88,200
Day's Range 86,500 - 88,700
52-Week Range 78,100 - 106,800
Beta 0.36
RSI 49.11
Earnings Date May 4, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1941
Employees 2,253
Stock Exchange Korea Stock Exchange
Ticker Symbol 185750
Full Company Profile

Financial Performance

In 2025, KRX:185750's revenue was 1.69 trillion, an increase of 6.68% compared to the previous year's 1.59 trillion. Earnings were 77.51 billion, a decrease of -28.94%.

Financial Statements

News

There is no news available yet.